Scott heads the Business Development team, building and delivering Optibrium’s global sales strategy and supporting discovery scientists to make scientifically robust decisions through the application of the software. Prior to joining Optibrium in 2021, Scott spent nearly 20 years with Lhasa Limited, an organization that develops predictive in silico methodologies, predominantly in the field of toxicology. He is a medicinal chemist by training, with an MChem in Chemistry with Medicinal Chemistry from the University of Salford.
Sign up to view 1 direct report
Get started
This person is not in any teams